Shire v Watson Lialda dispute heads back to district court
10-06-2015
blackboard1965 / Shutterstock.com
Biopharmaceutical company Shire has had a patent for Lialda (mesalamine) upheld in its trial against Watson Pharmaceuticals.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Shire, Lialda, US District Court for the Southern District of Southern, Abbreviated New Drug Application, Actavis, James Harrington, generics, patent,
